Literature DB >> 35296176

Healthcare utilization in multiple sclerosis: Impact of disease modifying therapies and comorbidities.

Alise Carlson1, Marisa P McGinley1.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35296176      PMCID： PMC8957556          DOI： 10.1177/13524585221081985

Source DB:  PubMed          Journal:  Mult Scler        ISSN： 1352-4585            Impact factor:   6.312


× No keyword cloud information.
  11 in total

Review 1.  The cost burden of multiple sclerosis in the United States: a systematic review of the literature.

Authors:  Gabriel Adelman; Stanley G Rane; Kathleen F Villa
Journal:  J Med Econ       Date:  2013-03-07       Impact factor: 2.448

2.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

Review 3.  A literature review of cost-of-illness studies on the economic burden of multiple sclerosis.

Authors:  Maria Paz-Zulueta; Paula Parás-Bravo; David Cantarero-Prieto; Carla Blázquez-Fernández; Agustín Oterino-Durán
Journal:  Mult Scler Relat Disord       Date:  2020-05-12       Impact factor: 4.339

Review 4.  How much is the cost of multiple sclerosis--systematic literature review.

Authors:  Katarzyna Kolasa
Journal:  Przegl Epidemiol       Date:  2013

5.  Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies.

Authors:  Gustavo Luna; Peter Alping; Joachim Burman; Katharina Fink; Anna Fogdell-Hahn; Martin Gunnarsson; Jan Hillert; Annette Langer-Gould; Jan Lycke; Petra Nilsson; Jonatan Salzer; Anders Svenningsson; Magnus Vrethem; Tomas Olsson; Fredrik Piehl; Thomas Frisell
Journal:  JAMA Neurol       Date:  2020-02-01       Impact factor: 18.302

Review 6.  Multidisciplinary data infrastructures in multiple sclerosis: Why they are needed and can be done!

Authors:  Liesbet M Peeters; Caspar Ep van Munster; Bart Van Wijmeersch; Robin Bruyndonckx; Ilse Lamers; Niels Hellings; Veronica Popescu; Christoph Thalheim; Peter Feys
Journal:  Mult Scler       Date:  2018-11-01       Impact factor: 6.312

7.  Emergency medical care for multiple sclerosis: A five-year population study in the Campania Region (South Italy).

Authors:  Marcello Moccia; Giuseppina Affinito; Bruno Ronga; Roberta Giordana; Maria Grazia Fumo; Roberta Lanzillo; Maria Petracca; Antonio Carotenuto; Maria Triassi; Vincenzo Brescia Morra; Raffaele Palladino
Journal:  Mult Scler       Date:  2022-04       Impact factor: 6.312

8.  New insights into the burden and costs of multiple sclerosis in Europe.

Authors:  Gisela Kobelt; Alan Thompson; Jenny Berg; Mia Gannedahl; Jennifer Eriksson
Journal:  Mult Scler       Date:  2017-02-01       Impact factor: 6.312

Review 9.  The Multiple Sclerosis Care Unit.

Authors:  Per Soelberg Sorensen; Gavin Giovannoni; Xavier Montalban; Christoph Thalheim; Paola Zaratin; Giancarlo Comi
Journal:  Mult Scler       Date:  2018-10-23       Impact factor: 6.312

10.  Disease-modifying drugs for multiple sclerosis and subsequent health service use.

Authors:  Huah Shin Ng; Feng Zhu; Elaine Kingwell; Yinshan Zhao; Shenzhen Yao; Okechukwu Ekuma; Lawrence W Svenson; Charity Evans; John D Fisk; Ruth Ann Marrie; Helen Tremlett
Journal:  Mult Scler       Date:  2021-12-24       Impact factor: 6.312
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.